As of Friday close, Virios Therapeutics Inc.’s (NASDAQ:VIRI) stock was up $0.05, moving up 4.17 percent to $1.25. The average number of shares traded per day over the past five days has been 1,021,820 shares. 3 times new highs have been achieved over the past 5 days, with a $0.3894 gain in that time frame. In the last twenty days, the average volume was 835,440, while in the previous 50 days, it was 798,278.
Since last month, VIRI stock retreated -39.02%. Shares of the company fell to $0.7916 on 08/11/23, the lowest level in the past month. A 52-week high of $8.83 was reached on 07/14/23 after having rallying from a 52-week low of $0.22. Since the beginning of this year, VIRI’s stock price has risen by 429.66% or $1.0140, and marked a new high 21 times. However, the stock has declined by -85.84% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
VIRI stock investors should be aware that Virios Therapeutics Inc. (VIRI) stock had its last reported insider trading activity 2 days ago on Aug 17. Duncan Gregory Scott, the CHIEF EXECUTIVE OFFICER of the company, purchased of 25,000 shares for $1.25 on Aug 17. It resulted in a $31,245 investment by the insider. Whitley Richard James sold 1,800 shares at an average price of $0.26 on Dec 08. The insider now owns 700 shares following the transaction.
Financial Health
In the three months ended June 29, Virios Therapeutics Inc.’s quick ratio stood at 11.90, while its current ratio was 11.90, showing that the company is able to pay off its debt.
While analysts expected Virios Therapeutics Inc. to report -$0.07 quarterly earnings, the actual figure was -$0.08 per share, beating the consensus estimate by -14.30%. The liabilities of Virios Therapeutics Inc. were 0.52 million at the end of its most recent quarter ended June 29. The value of shareholders’ equity is $19.25 million.
Technical Picture
This quick technical analysis looks at Virios Therapeutics Inc.’s (VIRI) price momentum. With a historical volatility rate of 259.83%, the RSI 9-day stood at 40.90% on 18 August.
With respect to its five-day moving average, the current Virios Therapeutics Inc. price is up by +45.25% percent or $0.3894. At present, VIRI shares trade -41.45% below its 20-day simple moving average and +224.59% percent above its 100-day simple moving average. However, the stock is currently trading approximately -19.35% below its SMA50 and +354.55% above its SMA200.
Stochastic coefficient K was 29.56% and Stochastic coefficient D was 22.72%, while ATR was 0.2239. Given the Stochastic reading of 40.00% for the 14-day period, the RSI (14) reading has been calculated as 40.76%. As of today, the MACD Oscillator reading stands at -0.0334, while the 14-day reading stands at -0.2448.
Analyst Ratings
Virios Therapeutics Inc. (VIRI) has been rated Hold by analysts. According to 0 brokerage firms, VIRI is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Virios Therapeutics Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $12.00, the current consensus forecast for the stock is $12.00 – $12.00. Based on these forecasts, analysts predict Virios Therapeutics Inc. (VIRI) will achieve an average price target of $12.00.
